A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal | NCT01882413 | Trialant
CompletedObservationalUpdated Dec 3, 2015
A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal
ClinicalTrials.gov ID
NCT01882413
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Observational
Enrollment
204Actual
Last Update Posted
Dec 3, 2015Estimated
Start Date
Jun 2013
Primary Completion Date
Mar 2014Actual
Completion Date
Mar 2014Actual
Brief Summary
This study will evaluate the prevalence of inflammatory dry eye disease in patients prior to cataract surgery. No treatment is administered in this study.
Dry Eye Syndromes
No intervention
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Scheduled to undergo cataract removal surgery
Exclusion Criteria:
Current use of eye drops or oral medications for allergic conjunctivitis
Serious ocular injury, intraocular surgery, or refractive surgery within 6 months in the study eye